Check out this post from Penn Center for Innovation highlighting GEMMABio and Franklin Biolabs! https://lnkd.in/eHvyV3vE
GEMMA Biotherapeutics
生物技术研究
Philadelphia，Pennsylvania 1,058 位关注者
Advancing gene therapy research and delivering life-changing therapeutics to patients around the world
关于我们
GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases. Alongside Franklin Biolabs, GEMMABio will advance gene therapy research and deliver therapeutics to patients around the world significantly faster.
- 网站
-
https://www.gemmabiotx.com/
GEMMA Biotherapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Philadelphia，Pennsylvania
- 类型
- 私人持股
- 创立
- 2024
- 领域
- Gene Therapy 、Rare Disease、Quality Assurance、GXP operations、Regulatory affairs、Clinical development、Discovery research、Translational research、Vector research、Biomedical research、Orphan disease、Genetic disease、Genetic medicine、AAV vectors、Bioinformatics、Capsid engineering和Genome editing
地点
-
主要
获取路线
125 S 31st St
US，Pennsylvania，Philadelphia，19104
GEMMA Biotherapeutics员工
动态
-
Endpoints News ran a story on the GEMMABio partnership with Fiocruz. Read more here: https://lnkd.in/eGnX6NQs
Jim Wilson secures $100M for global approach aimed at reviving gene therapy field
endpts.com
-
The Philadelphia Business Journal ran a story on GEMMABio's recent international partnership agreement with Fiocruz. https://lnkd.in/eySmFAjF
Jim Wilson's Gemma Biotherapeutics gets up to $100M in funding - Philadelphia Business Journal
bizjournals.com
-
GEMMABio's recent agreement with Fiocruz in Brazil was highlighted in this story by Fierce Biotech. https://lnkd.in/eKk_cCX8
GEMMABio secures $100M partnership with health ministry to bring rare disease gene therapies to Brazil
fiercebiotech.com
-
Check out The Philadelphia Inquirer's coverage of our new partnership with Fiocruz, featured on the first page of the Business & Money section in today's paper! https://lnkd.in/eiuc32pV
Jim Wilson’s new gene therapy company Gemma is getting up to $100M from Brazil
inquirer.com
-
Today, GEMMABio announced a $100 million agreement with Fiocruz, Brazil's leading health research institute, to conduct clinical research and manufacturing for several rare disease programs. Read more: https://lnkd.in/eMH2ynNJ
GEMMABio Announces $100 Million Agreement with Brazil's Leading Health Research Institute
prnewswire.com